What primary objective drives the US to exempt certain pharmaceutical licensing from broad trade restrictions with China?

💡 Explanation:

US trade policy often differentiates pharmaceuticals from other high-tech sectors to maintain global health supply chains and medical innovation while simultaneously restricting dual-use biotechnology for national security reasons.